High risk oral contraceptive hormones do not directly enhance endothelial cell procoagulant activity in vitro

HIGHLIGHTS

  • who: Emma G. Bouck and collaborators from the Department of Pathology and Laboratory Medicine and UNC Blood Research Center, University of North have published the Article: High risk oral contraceptive hormones do not directly enhance endothelial cell procoagulant activity in vitro, in the Journal: PLOS ONE of 15/Dec/2022
  • how: To determine whether OC hormones provoke EC prothrombotic activity the authors designed an in_vitro model of the plasma-endothelial interface. The authors developed an in_vitro model of the endothelial-blood interface to study primary direct effects of high-risk hormones on endothelial cells.
  •  

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?